Factors that modify radiation-induced carcinogenesis

Health Physics

Volumn 97, Issue 5, 2009, Pages 433-445

  Kennedy, Ann R ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cancer; Carcinogenesis; Environmental assessment; National Council on Radiation Protection and Measurements

Indexed keywords

ALPHA 2 MACROGLOBULIN; ALPHA TOCOPHEROL; AMIFOSTINE; ANTIOXIDANT; BETA CAROTENE; CORTISONE; PROTEINASE INHIBITOR; RETINOID; RETINOL; VITAMIN D;

BREAST CANCER; CANCER RISK; CLINICAL TRIAL; CONFERENCE PAPER; DIET; DIET RESTRICTION; DRUG EFFICACY; FIBROMA; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LUNG CANCER; LYMPHOMA; NONHUMAN; PRIORITY JOURNAL; RADIATION CARCINOGENESIS; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION;

ANIMALS; DIET; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; NEOPLASMS, RADIATION-INDUCED; RADIATION DOSAGE; RISK;

ANIMALIA;

EID: 70350431280     PISSN: 00179078     EISSN: None     Source Type: Journal    
DOI: 10.1097/HP.0b013e3181ac9262     Document Type: Conference Paper

References (122)

1. Archer VE, Gillam JD, Wagoner JK. Respiratory disease among uranium miners. Ann NY Acad Sci: 271:280-293; 1976.
2. Barnes S, Grubbs C, Setchell KDR, Carlson J. Soybeans inhibit mammary tumors in models of breast cancer. Prog Clin Biol Res 347:239-252; 1990.
3. Becker FF. Inhibition of spontaneous hepatocarcinogenesis in C3H/Hen mice by Edi Pro A, an isolated soy protein. Carcinogenesis 2:1213-1214; 1981.
4. Beral V, Inskip H, Fraser P, Booth M, Coleman D, Rose G. Mortality of employees of the United Kingdom Atomic Energy Authority, 1946-1979. Br Med J 291:440-447; 1985.
5. Berenblum I. Carcinogenesis as a biological problem. Amsterdam: North Holland Publishing Co.; 1974: 133-141.
6. Berenblum I, Burger M, Knyszynski A. Inhibition of radiationinduced lymphatic leukemia in C57BL mice by 19S alpha2-globulin (alpha 2-MG) from human blood serum. Radiat Res 60:501-505; 1974.
7. BillingsPC,NewberneP,KennedyAR. Proteaseinhibitorsuppressionofcolonandanalglandcarcinogenesisinducedbydimethylh ydrazine.Carcinogenesis11:1083-1086;1990.(Pubitemid20236265)
8. Blumberg PM. In vitro studies on the mode of action of the phorbol esters. Potent tumor promoters: Parts 1 and 2, CRC Critical Review. Toxicol 8:153-197; 199-234; 1980 and 1981.
9. BoiceJDJr,DayNE,AndersenA,BrintonLA,BrownR,ChoiNW,ClarkeEA,ColemanMP, CurtisRE,FlanneryJT,HakamaM,HakulinenT,HoweGR,JensenOM,KleinermanRA,MagninD, MagnusK,MakelaK,MalkerB,MillerAB,NelsonN,PattersonCC,PetterssonF,Pompe-KirnV, PrimicZakeljM,PriorP,RavniharB,SkeetRG,SkjervenJE,SmithPG,SokM,SpenglerRF, StormHH,StovallM,TomkinsGWO,WallC. Secondcancersfollowingradiationtreatmentforcervicalcancer. Aninternationalcollaborationamongcancerregistries.JNatlCancerInst74: 955-975;1985.(Pubitemid15062953)
10. Bond VP, Cronkite EP, Lippincott SW, Shellabarger CJ. Studies on radiation-induced mammary gland neoplasia in the rat. III. Relation of the neoplastic response to dose of total-body radiation. Radiation Res 12:276-285; 1960.
11. Boutwell RK. Model systems for defining initiation, promotion, and progression of skin neoplasms. Progress Clinical Biological Res 298:3-15; 1989.
12. Buell P. Changing incidence of breast cancer in JapaneseAmerican women. J Natl Cancer Inst 51:1479-1483; 1973.
13. Burns FJ, Tang M-S, Frenkel K, Nadas A, Wu F, Uddin, Zhang R. Induction and prevention of carcinogenesis in rat skin exposed to space radiation. Radiat Environ Biophys 46:195-199; 2007. (Pubitemid 46726010)
14. Carnes BA, Grdina DJ. In vivo protection by the aminothiol WR-2721 against neutron induced carcinogenesis. Int J Radiat Biol 61:567-576; 1992.
15. CorreaP.Epidemiologicalcorrelationsbetweendietandcancerfrequency. CancerRes41:3685-3690;1981.(Pubitemid11052036)
16. DarbySC,DollR,GillSK,SmithPG.Long- termmortalityafterasingletreatmentcoursewithx- raysinpatientstreatedforankylosingspondylitis.BrJCancer55:179-190;1987. (Pubitemid17021681)
17. Dittmann KH, Mayer C, Rodemann HP. Radioprotection of normal tissue to improve radiotherapy: the effect of the Bowman Birk protease inhibitor. Curr Med Chem Anticancer Agents 3:360-363; 2003. (Pubitemid 37045714)
18. Dittmann K, Toulany M, Classen V, Heinrich V, Milas L, Rodemann HP. Selective radioprotection of normal tissues by Bowman-Bir proteinase inhibitor (BBI) in mice. Strahlenther Onkol 181:191-196; 2005. (Pubitemid 40500903)
19. DollR,PetoR.Thecausesofcancer: quantitativeestimatesofavoidablerisksofcancerintheUnitedStatestoday. JNatlCancerInst66:1192-1308;1981.(Pubitemid11063920)
20. Doniach I. Carcinogenic effect of 100, 250 and 500 rad x-rays on the rat thyroid gland. Brit J Cancer 30:487-495; 1974.
21. Dunn JE. Cancer epidemiology in populations of the United States with emphasis on Hawaii and California and Japan. Cancer Res 35:3240-3245; 1975.
22. Epstein JH, Roth HL. Experimental ultraviolet light carcinogenesis: a study of croton oil promoting effects. J Invest Derm 50:387-389; 1968.
23. Foster RS Jr. Thyroid irradiation and carcinogenesis. Review with assessment of clinical implications. Am J Surg 130:608-611; 1975.
24. Fry RJM, Ley RR. Ultraviolet radiation carcinogenesis. In: Slaga TJ, ed. Mechanisms of tumor promotion, vol.2. Boca Raton, FL: CRC Press; 1984: 73-96.
25. Furth J. Hormones as etiological agents in neoplasia. In: Becker FF, ed. Cancer, a comprehensive treatise, vol.1, Etiology: chemical and physical carcinogenesis. New York: Plenum Press; 1975: 89-134.
26. Gong JK. Anemic stress as a trigger of myelogenous leukemia in rats rendered leukemia-prone by x-ray. Science 174:833-835; 1971.
27. Gottlieb LS, Husen LA. Lung cancer among Navajo uranium miners. Chest 81:449-452; 1982.
28. Grdina, DJ, Murley JS, Kataoka Y. Radioprotectants: current status and new directions. Oncol 63(Suppl 2):2-10; 2002.
29. Grobstein C, Cairns J, Broitman SA, Campbell TC, Gussow JD, Kolonel LN, Kritchevsky D, Mertz W, Miller AB, Privai MJ, Slaga T, Wattenberg L, Sugimura T. Diet, nutrition and cancer. Washington, DC: National Academy Press, Committee on Diet, Nutrition and Cancer, Assembly of Life Sciences, National Research Council; 1982.
30. Haenszel W, Kurihara M. Studies of Japanese immigrants. I. Mortality from cancer and other diseases among Japanese in the U.S. J Natl Cancer Inst 40:43-69; 1968.
31. Hall WH. The role of initiating and promoting factors in the pathogenesis of tumors of the thyroid. Brit J Cancer 2:273-280; 1948.
32. HigginsonJ,MuirCS.Environmentalcarcinogenesis: misconceptionsandlimitations-cancercontrol.JNatlCancerInst63:1291-1298;1979. (Pubitemid10203638)
33. Howe GR, McLaughlin J. Breast cancer mortality between 1950 and 1987 after exposure to fractionated moderatedose-rate ionizing radiation in the Canadian fluoroscopy cohort study and a comparison with breast cancer mortality in the atomic bomb survivors study. Radiat Res 145:694-707; 1996.
34. Kaplan HS, Brown MB. Testosterone prevention of postirradiation lymphomas in C57 black mice. Cancer Res 12:445-447; 1952.
35. Kaplan HS, Marder SN, Brown MB. Adrenal cortical function and radiation-induced tumors of mice. Cancer Res 11:629-633; 1951.
36. Kennedy AR. Promotion and other interactions between agents in the induction of transformation in vitro in fibroblasts. In: Slaga TJ, ed. Mechanisms of tumor promotion, vol.III. Tumor promotion and carcinogenesis in vitro. New York: CRC Press; 1984a: 13-50.
37. Kennedy AR. Prevention of radiation-induced transformation in vitro. In: Prasa KN, ed. Vitamins, nutrition and cancer. Basel, Switzerland: S. Karger AG; 1984b: 166-179.
38. Kennedy AR. Relevance of tumor promotion to carcinogenesis in human populations. In: Mass MJ, Kaufman DG, Siegfried JM, Steele VE, Nesnow S, eds. Cancer of the respiratory tract: predisposing factors, carcinogenesis-a comprehensive survey, volume 8. New York: Raven Press; 1985: 431-436.
39. Kennedy AR. Role of free radicals in the initiation and promotion of radiation-induced and chemical carcinogen induced cell transformation. In: Breccia A, Rodgers MAJ, Semerano G, eds. Oxygen and sulfur radicals in chemistry and medicine. Bologna, Italy: Edizioni Scientifiche, Lo Scarabeo; 1986: 201-209.
40. Kennedy AR. Radiation injury and carcinogenesis. In: Honn KV, Marnett LJ, Nigam S, Waiden T, eds. Eicosanoids and bioactive lipids in cancer and radiation injury. Dordrecht, The Netherlands: KIuwer Publishers; 1991: 51-59.
41. Kennedy AR. Overview: Anticarcinogenic activity of protease inhibitors. In: Troll W, Kennedy A, eds. Protease inhibitors as cancer chemopreventive agents. New York: Plenum Publishing; 1993a: 9-64.
42. Kennedy AR. In vitro studies of anticarcinogenic protease inhibitors. In: Troll W, Kennedy A, eds. Protease inhibitors as cancer chemopreventive agents. New York: Plenum Press; 1993b: 65-91.
43. Kennedy AR. The modification of radiation induced transformation in vitro by chemicals. In: Hagen U, Harder D, Jung H, Steffer C, eds. Radiation research: 1895-1995. Congress Proceedings Volume2: Congress Lectures (Symposium- Combined effects of chemicals and radiation on oncogenic cell transformation). Wurzburg: Universitatsdruckerei H. Sturtz AG; 1995a: 607-610.
44. Kennedy AR. The evidence for soybean products as cancer preventive agents. J Nutr 125:733s-743s; 1995b.
45. Kennedy AR. Chemopreventive agents: protease inhibitors. Pharmacology & Therapeutics 78:167-209; 1998.
46. Kennedy AR. The status of human trials utilizing BowmanBirk inhibitor concentrate from soybeans. In: Sugano M, ed. Soy in health and disease prevention. Boca Raton, FL: CRC Press; 2005: 207-223.
47. Kennedy AR, Little JB. Radiation carcinogenesis in the respiratory tract. In: Harris CC, ed. Pathogenesis and therapy of lung cancer. New York: Marcel Dekker, Inc.; 1978: 189-261.
48. Kennedy AR, Little JB. Evidence that a second event in x-ray induced oncogenic transformation in vitro occurs during cellular proliferation. Radiat Res 99:228-248; 1984.
49. KennedyAR,MondaiS,HeidelbergerC,LittleJB.Enhancementofx- raytransformationby12-0-tetradecanoylphorbol-13- acetateinaclonedlineofC3Hmouseembryocells.CancerRes38:439-443;1978. (Pubitemid8283969)
50. KennedyAR,BillingsPC,MakiPA,NewberneP. Effectsofvariouspreparationsofdietaryproteaseinhibitorsonoralcarcinogenesisinh amstersinducedbyDMBA.NutrCancer19:191-200;1993a.(Pubitemid23131436)
51. Kennedy AR, Szuhaj BF, Newberne PM, Billings PC. Preparation and production of a cancer chemopreventive agent, Bowman-Birk inhibitor concentrate. Nutr Cancer 19:281-302; 1993b.
52. KennedyAR,Beazer-BarclayY,KinzlerKW,NewbernePM. SuppressionofcarcinogenesisintheintestinesofMinmicebythesoybean-derivedBowman- Birkinhibitor.CancerRes56:679-682;1996.(Pubitemid26055451)
53. Kennedy AR, Billings PC, Wan XS, Newberne PM. Effects of the Bowman-Birk inhibitor on rat colon carcinogenesis. Nutr Cancer 43:174-186; 2002.
54. Kennedy AR, Davis JG, Carlton W, Ware JH. Effects of dietary antioxidant supplementation on the development of malignant lymphoma and other neoplastic lesions in mice exposed to proton or iron ion radiation. Radiat Res 169:615-625; 2008. (Pubitemid 351793451)
55. Land CE, Tokunaga M, Koyama K, Soda M, Preston DL, Nishimori I, Tokuoka S. Incidence of female breast cancer among atomic bomb survivors, Hiroshima and Nagasaki, 1950-1990. Radiat Res 160:707-717; 2003.
56. Liener IE, Hasdai A. The effect of long-term feeding of raw soy flour on the pancreas of mouse and hamster. Adv Exp Med Biol 199:189-197; 1986.
57. Little MP, Boice JD Jr. Comparison of breast cancer incidence in the Massachusetts Tuberculosis Fluoroscopy cohort and in the Japanese atomic bomb survivors. Radiat Res 151:218-224; 1999.
58. Little MP, Boice JD Jr. Analysis of breast cancer in the Massachusetts TB fluoroscopy cohort and in the Japanese A-bomb survivors, taking account of dosimetric error and curvature in the A-bomb dose response: absence of evidence of reduction of risk following fractionated irradiation. Int J Low Radiat 1:88-101; 2003.
59. Little JB, Kennedy AR. Promotion of x-ray transformation in vitro. In: Hecker E, Fusenig NE, Kunz W, Marks F, Thielmann JW, eds. Carcinogenesis, vol.7: Cocarcinogenesis and biological effects of tumor promoters. New York: Raven Press; 1982: 155-165.
60. Little JB, McGandy RB, Kennedy AR. Interactions between polonium-210, benzo(a)pyrene, and 0.9% NaCl solution instillations in the induction of experimental lung cancer. Cancer Res 38:1929-1935; 1978.
61. Littman SM, Hong WK. Cancer prevention by delay. Clin Cancer Res 8:305-313; 2002.
62. Lundin FE, Wagoner JK, Archer VE. Radon daughter exposure and respiratory cancer: quantitative and temporal aspects. NIOSH and NIEHS Joint Monograph No. 1. Springfield, VA: National Technical Information Service; 1971.
63. Matanoski GM, Seltzer R, Sartwell PE, Diamond EL, Elliott EA. The current mortality rates of radiologists and other physician specialists: specific causes of death. Am J Epidemiol 101:199-210; 1975.
64. Maxon HR, Thomas SR, Saenger EL, Buncher CR, Kereiakes JG. Ionizing irradiation and the induction of clinically significant disease in the human thyroid gland. Am J Med 63:967-978; 1977.
65. McCormick DL, Johnson WD, Bosland MC, Lubet RA, Steele VWE. Chemoprevention of rat prostate carcinogenesis by soy isoflavones and by Bowman Birk inhibitor. Nutr Cancer 57:184-193; 2007.
66. MessadiDV,BillingsP,ShklarG,KennedyAR. Inhibitionoforalcarcinogenesisbyaproteaseinhibitor.JNatlCancerInst76: 447-452;1986.(Pubitemid16119780)
67. Messina MJ, Barnes S. The role of soy products in reducing the risk of cancer. J Natl Cancer Inst 83:541-546; 1991.
68. MessinaMJ,PerskyV,SetchellKDR,BarnesS.Soyintakeandcancerrisk: areviewoftheinvitroandinvivodata.NutrCancer21:113-131;1994.(Pubitemid24127628)
69. Moloney MA, Marguilis AR, Patt HM. Myeooid leukemia: Does blood loss increase the incidence in x-irradiated rats? Science 180:761-762; 1973.
70. National Research Council, Committee on the Biological Effects of Ionizing Radiation. The effects on populations of exposure to low levels of ionizing radiation. Washington, DC: National Academy Press; BEIR III; 1980.
71. National Research Council, Committee on the Biological Effects of Ionizing Radiation. Health risks of radon and other internally deposited alpha-emitters. Washington, DC: National Academy Press; BEIR IV; 1988.
72. National Research Council, Committee on the Biological Effects of Ionizing Radiation. Health effects of exposure to low levels of ionizing radiation. Washington, DC: National Academy Press; BEIR V; 1990.
73. National Research Council, Committee on the Biological Effects of Ionizing Radiation. Health risks from exposure to low levels of ionizing radiation. Washington, DC: National Academy Press; BEIR VII; 2006.
74. Nitta Y, Kamiya K, Yokoro K. Carcinogenic effect of in utero 252Cf and 60Co irradiation in C57BL/6N x C3H/He F1 (B6C3F1) mice. Radiat Res (Tokyo) 33:319-333; 1992.
75. O'Shaughnessy JA, Kelloff GJ, Gordon GB, Dannenberg AJ, Hong WK, Fabian CJ, Sigman CC, Bertagnolli MM, Stratton SP, Lam S, Nelson WG, Meyskens FL, Alberts DS, Folien M, Rustgi AK, Papadimitrakopoulou V, Scardino PT, Gazdar AF, Wattenberg LW, Sporn MB, Sakr WA, Lippman SM, Von Hoff DD. Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development. Clin Cancer Res 8:314-346; 2002.
76. Pound AW. Induced cell proliferation and the initiation of skin tumor formation in mice by ultraviolet light. Pathol 2:269-275; 1970.
77. PrestonDL,MattssonA,HolmbergE,ShoreR,HildrethNG,BoiceJDJr. Radiationeffectsonbreastcancerrisk:apooledanalysisofeightcohorts.RadiatRes158: 220-235;2002.(Pubitemid34851818)
78. Preston DL, Ron E, Tokuoka S, Funamoto S, Nishi N, Soda M, Mabuchi K, Kodama K. Solid cancer incidence in atomic bomb survivors: 1958-1998. Radiat Res 168:1-64; 2007.
79. Raicht RF, Cohen BI, Fazzini EP, Sarwal AN, Takahashi M. Protective effect of plant sterols against chemically induced colon tumors in rats. Cancer Res 40:403-405; 1980.
80. Ryser HJP. Chemical carcinogenesis. New Engl J Med 285:721-734; 1971.
81. Samet JM, Kutvirt DM, Waxweiler RJ, Key CR. Uranium mining and lung cancer in Navajo men. New Engl J Med 310:1481-1484; 1984.
82. Sauvaget C, Nagano J, Hayashi M, Spencer E, Shimizu Y, Allen N. Vegetables and fruit intake and cancer mortality in the Hiroshima/Nagasaki Life Span Study. Br J Cancer 88:689-694; 2003. (Pubitemid 36411445)
83. Sauvaget C, Kasagi F, Waldren CA. Dietary factors and cancer mortality among atomic-bomb survivors. Mutation Res 551:145-152; 2004. (Pubitemid 38833504)
84. Sauvaget C, Lagarde F, Nagano J, Soda M, Koyama K, Kodama K. Lifestyle factors, radiation and gastric cancer in atomic-bomb survivors (Japan). Cancer Causes Control 16:773-780; 2005. (Pubitemid 41160041)
85. 210Po alpha-radiation. Cancer Res 42:1405-1411; 1982.
86. ShamsuddinAN,UllahA. InositolhexaphosphateinhibitslargeintestinalcancerinF344rats5monthsafterind uctionbyazoxymethane.Carcinogenesis10:625-626;1989.(Pubitemid19089937)
87. ShamsuddinAM,ElsayedAM,UllahA. SuppressionoflargeintestinalcancerinF344ratsbyinositolhexaphosphate. Carcinogenesis9:577-580;1988.(Pubitemid18106726)
88. ShamsuddinAM,UllahA,ChakravarthyAK. InositolandinositolhexaphosphatesuppresscellproliferationandtumorformationinCD- 1mice.Carcinogenesis10:1461-1463;1989.(Pubitemid19197465)
89. Sharp GB, Lagarde F, Mizuno T, Sauvaget C, Fukuhara T, Allen N, Suzuki G, Tokuoka S. Relationship of hepatocellular carcionoma to soya food consumption: a cohort-based, case-control study in Japan. Int J Cancer 115:290-295; 2005. (Pubitemid 40586739)
90. Shubik P, Goldfarb AR, Ritchie AC, Lisco H. Latent carcinogenic action of beta radiation on mouse epidermis. Nature 171:934-935; 1953.
91. Sipos E. Dietary trends for vegetable proteins in foods. Inform 1:753-757; 1990.
92. St.ClairW,BillingsP,CarewJ,Keller-McGandyC,NewberneP,KennedyAR. SuppressionofDMH-inducedcarcinogenesisinmicebydietaryadditionoftheBowman- Birkproteaseinhibitor.CancerRes50:580-586;1990.(Pubitemid20054182)
93. Suss R, Kinzel V, Scribner JD. Cancer experiments and concepts. New York: Springer-Verlag; 1973.
94. Thompson DE, Mabuchi K, Ron E, Soda M, Tokunaga M, Ochikubo S, Sugimoto S, Ikeda T, Terasaki M, Izumi S, Preston DL. Cancer incidence in atomic bomb survivors Part II: Solid tumors, 1958-1987. Radiat Res 137:S17-S67; 1994.
95. Tominaga S. Cancer incidence in Japanese in Japan, Hawaii, and western United States. Natl Cancer Inst Monogr 69:83-92; 1985.
96. Troll W. Blocking tumor promotion by protease inhibitors. In: Magee PN, Takayama S, Sugimura T, Matsushima, T, eds. Fundamentals in cancer prevention. Baltimore, MD: University Park Press; 1976: 41-55.
97. TrollW,WiesnerR,BelmanS,ShellabargerCJ. Inhibitionofcarcinogenesisbyfeedingdietscontainingsoybeans. ProcAmAssocCancerRes20:265;1979a.(Pubitemid9189226)
98. Troll W, Belman S, Wiesner R, Shellabarger CJ. Protease action in carcinogenesis. In: Holtzer H, Tschesche H, eds. Biological functions of proteinases. New York: SpringerVerlag; 1979b: 165-170.
99. TrollW,WiesnerR,ShellabargerC,HoltzmanS,StoneJP. Soybeandietlowersbreasttumorincidenceinirradiatedrats.Carcinogenesis1: 469-472;1980.(Pubitemid11181971)
100. United State Scientific Committee on the Effects of Atomic Radiation. Sources and effects of ionizing radiation. Report to the General Assembly, with annexes. New York: United Nations; 1977.
101. United Nations Scientific Committee on the Effects of Atomic Radiation. UNSCEAR 1994 Report to the General Assembly, with Scientific Annexes. Sources and effects of ionizing radiation. New York: United Nations; 1994.
102. United Nations Scientific Committee on the Effects of Atomic Radiation. UNSCEAR 2000 Report to the General Assembly, with Scientific Annexes. Volume II: Effects, Annex I: Epidemiological evaluation of radiation-induced cancer. New York: United Nations; 2000.
103. Upton AC, Jenkins UK, Conklin JW. Myeloid leukemia in the mouse. Ann NY Acad Sci 114:189-201; 1964.
104. Von Hofe E, Newberne PM, Kennedy AR. Inhibition of N- nitrosomethylbenzylamine induced esophageal neoplasms by the Bowman-Birk protease inhibitor. Carcinogenesis 12:2147-2150; 1991.
105. Vucenik I, Sakamoto K, Bansal M, Shamsuddin AM. Inhibition of rat mammary carcinogenesis by inositol hexaphosphate (phytic acid). A pilot study. Cancer Lett 75:95-102; 1993. (Pubitemid 24014532)
106. Walburg HE Jr, Cosgrove GE, Upton AC. Influence of microbial environment on development of myeloid leukemia in x-irradiated RFM mice. Int J Cancer 3:150-154; 1968.
107. Wan XS, Ware JH, Zhang L, Newberne PM, Evans S, Clark LC, Kennedy AR. Treatment with the soybean-derived Bowman-Birk inhibitor increases the serum prostate specific antigen concentration while suppressing the growth of human prostate cancer xenografts in nude mice. The Prostate 41:243-252; 1999.
108. Wan XS, Ware JH, Zhou Z, Donahue JJ, Kennedy AR. Protection against radiation induced oxidative stress in cultured human epithelial cells by treatment with antioxidant agents. Int J Radiat Oncol Biol Phys 64:1475-1481; 2006.
109. Wasi P, Block M. The histopathologic study of the development of the irradiation-induced leukemia in C57BL mice and its inhibition by testosterone. Cancer Res 21:463-473; 1961.
110. Wattenberg LW. Inhibition of chemical carcinogenesis. J Natl Cancer Inst 60:11-18; 1978.
111. Wattenberg LW. Chemoprevention of cancer. Cancer Res 45:1-8; 1985.
112. WeedH,McGandyRB,KennedyAR. Protectionagainstdimethylhydrazineinducedadenomatoustumorsofthemousecolonby thedietaryadditionofanextractofsoybeanscontainingtheBowman- Birkproteaseinhibitor.Carcinogenesis6:1239-1241;1985.(Pubitemid15041880)
113. Weinstein IB, Wigler M, Pietropaolo C. The action of tumorpromoting agents in cell culture. In: Watson JD, Winsten JA, eds. Origins of human cancer. Cold Spring Harbor Conferences on Cell Proliferation, Vol.4. New York: Cold Spring Harbor Laboratory; 1977: 751-752.
114. Weiss HA, Darby SC, Fearn T, Doll R. Cancer mortality following x-ray treatment for ankylosing spondylitis. Int J Cancer 59:327-338; 1994. (Pubitemid 24331822)
115. Weiss JF, Landauer R. Radioprotection by antioxidants. Ann NY Acad Sci 899:44-60; 2000.
116. Weiss JF, Landauer MR. Protection against ionizing radiation by antioxidant nutrients and phytochemicals. Toxicol 189:1-20; 2003.
117. WitschiH,KennedyAR.Modulationoflungtumordevelopmentinmicewiththesoybean- derivedBowman-Birkproteaseinhibitor.Carcinogenesis10:2275-2277;1989. (Pubitemid20009109)
118. Wynder EL, Hoffmann D, McCoy D, et al. Tumor promotion and co-carcinogenesis as related to man and his environment. In: Slaga TJ, Sivak A, Boutwell RK, eds. Carcinogenesis: a comprehensive survey, Vol.2. New York: Raven Press; 1978: 59-77.
119. Yavelow J, Finlay TH, Kennedy AR, Troll W. Bowman-Birk soybean protease inhibitor as an anticarcinogen. Cancer Res 43:2454-2459; 1983.
120. Yavelow J, Collins M, Birk Y, Troll W, Kennedy AR. Nanomolar concentrations of Bowman-Birk soybean protease inhibitor suppress x-ray induced transformation in vitro. Proc Natl Acad Sci USA 82:5395-5399; 1985.
121. Yoshida K, Inoue T, Hirabayashi Y, Matsumura T, Nemoto K, Sado T. Radiation-induced myeloid leukemia in mice under calorie restriction. Leukemia 11(Suppl):410-412; 1997a.
122. Yoshida K, Tohru I, Nojima K, Hirabayashi Y, Sado T. Calorie restriction reduces the incidence of myeloid leukemia induced by a single whole-body radiation in C3H/He mice. Proc Natl Acad Sci USA 94:2615-2619; 1997b. (Pubitemid 27136924)